- Gynaecological
Name | No. | Patient Profile | Purpose |
---|---|---|---|
Athena | CTRIAL-IE 18-26 | Ovarian cancer |
The purpose of this study is to investigate if two medications; Rucaparib and Nivolumab used together or separately are better than the current best available treatment for patients who have had platinum-based chemotherapy for ovarian cancer. |